Swedish pharmaceuticals regulation: “Masking” political decision-making
In 2002, the Swedish government established an autonomous organization to make decisions about the public subsidization of prescription drugs. The notion was that these were technical decisions best left to experts. In the current issue of Governance (24.1, January 2011), Asa Casula Vifell and Ebba Sjörgren (Södertörn University, Stockholm University) challenge this view. The questions addressed by the new organization are “ambiguous and uncertain,” they argue. The 2002 reform has created “a situation whereby political considerations are made invisible, masked by ostensibly neutral procedures and techniques.” Read the article.